UniProt ID | RAI3_HUMAN | |
---|---|---|
UniProt AC | Q8NFJ5 | |
Protein Name | Retinoic acid-induced protein 3 | |
Gene Name | GPRC5A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 357 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . Cytoplasmic vesicle membrane Multi-pass membrane protein . Localized in perinuclear vesicles, probably Golgi-associated vesicles. |
|
Protein Description | Orphan receptor. Could be involved in modulating differentiation and maintaining homeostasis of epithelial cells. This retinoic acid-inducible GPCR provide evidence for a possible interaction between retinoid and G-protein signaling pathways. Functions as a negative modulator of EGFR signaling (By similarity). May act as a lung tumor suppressor. [PubMed: 18000218] | |
Protein Sequence | MATTVPDGCRNGLKSKYYRLCDKAEAWGIVLETVATAGVVTSVAFMLTLPILVCKVQDSNRRKMLPTQFLFLLGVLGIFGLTFAFIIGLDGSTGPTRFFLFGILFSICFSCLLAHAVSLTKLVRGRKPLSLLVILGLAVGFSLVQDVIAIEYIVLTMNRTNVNVFSELSAPRRNEDFVLLLTYVLFLMALTFLMSSFTFCGSFTGWKRHGAHIYLTMLLSIAIWVAWITLLMLPDFDRRWDDTILSSALAANGWVFLLAYVSPEFWLLTKQRNPMDYPVEDAFCKPQLVKKSYGVENRAYSQEEITQGFEETGDTLYAPYSTHFQLQNQPPQKEFSIPRAHAWPSPYKDYEVKKEGS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | S-palmitoylation | ATTVPDGCRNGLKSK CCCCCCCCCCCCHHH | 3.89 | 19801377 | |
59 | Phosphorylation | LVCKVQDSNRRKMLP HHEEECCCCHHCCCH | 18.36 | 23401153 | |
158 | N-linked_Glycosylation | EYIVLTMNRTNVNVF HHHECCCCCCCCCEE | 42.25 | UniProtKB CARBOHYD | |
169 | Phosphorylation | VNVFSELSAPRRNED CCEEHHHCCCCCCHH | 31.98 | 24719451 | |
277 | Phosphorylation | KQRNPMDYPVEDAFC CCCCCCCCCCCCCCC | 11.70 | 28152594 | |
284 | S-palmitoylation | YPVEDAFCKPQLVKK CCCCCCCCCHHHHCH | 7.24 | 19801377 | |
285 | Acetylation | PVEDAFCKPQLVKKS CCCCCCCCHHHHCHH | 29.37 | 26051181 | |
285 | Ubiquitination | PVEDAFCKPQLVKKS CCCCCCCCHHHHCHH | 29.37 | 21963094 | |
290 | 2-Hydroxyisobutyrylation | FCKPQLVKKSYGVEN CCCHHHHCHHHCCCC | 44.59 | - | |
290 | Ubiquitination | FCKPQLVKKSYGVEN CCCHHHHCHHHCCCC | 44.59 | 27667366 | |
291 | Ubiquitination | CKPQLVKKSYGVENR CCHHHHCHHHCCCCC | 41.24 | 22817900 | |
292 | Phosphorylation | KPQLVKKSYGVENRA CHHHHCHHHCCCCCC | 22.77 | 28152594 | |
293 | Phosphorylation | PQLVKKSYGVENRAY HHHHCHHHCCCCCCC | 33.79 | 28152594 | |
300 | Phosphorylation | YGVENRAYSQEEITQ HCCCCCCCCHHHHHH | 13.98 | 21955146 | |
301 | Phosphorylation | GVENRAYSQEEITQG CCCCCCCCHHHHHHC | 30.08 | 25159151 | |
306 | Phosphorylation | AYSQEEITQGFEETG CCCHHHHHHCCHHHC | 26.39 | 21955146 | |
312 | Phosphorylation | ITQGFEETGDTLYAP HHHCCHHHCCCEEEC | 32.91 | 25159151 | |
315 | Phosphorylation | GFEETGDTLYAPYST CCHHHCCCEEECCCC | 24.02 | 21082442 | |
317 | Phosphorylation | EETGDTLYAPYSTHF HHHCCCEEECCCCCE | 13.97 | 30175587 | |
320 | Phosphorylation | GDTLYAPYSTHFQLQ CCCEEECCCCCEECC | 20.30 | 25311788 | |
321 | Phosphorylation | DTLYAPYSTHFQLQN CCEEECCCCCEECCC | 17.85 | 30175587 | |
322 | Phosphorylation | TLYAPYSTHFQLQNQ CEEECCCCCEECCCC | 22.36 | 21082442 | |
333 | Ubiquitination | LQNQPPQKEFSIPRA CCCCCCCCCCCCCCC | 67.51 | 21906983 | |
336 | Phosphorylation | QPPQKEFSIPRAHAW CCCCCCCCCCCCCCC | 32.54 | 25463755 | |
345 | Phosphorylation | PRAHAWPSPYKDYEV CCCCCCCCCCCCCCC | 30.11 | 22167270 | |
347 | Phosphorylation | AHAWPSPYKDYEVKK CCCCCCCCCCCCCCC | 22.34 | 25159151 | |
348 | 2-Hydroxyisobutyrylation | HAWPSPYKDYEVKKE CCCCCCCCCCCCCCC | 58.16 | - | |
348 | Ubiquitination | HAWPSPYKDYEVKKE CCCCCCCCCCCCCCC | 58.16 | 23000965 | |
350 | Phosphorylation | WPSPYKDYEVKKEGS CCCCCCCCCCCCCCC | 20.62 | 21945579 | |
353 | Ubiquitination | PYKDYEVKKEGS--- CCCCCCCCCCCC--- | 32.92 | 23000965 | |
354 | Ubiquitination | YKDYEVKKEGS---- CCCCCCCCCCC---- | 72.92 | 23000965 | |
357 | Phosphorylation | YEVKKEGS------- CCCCCCCC------- | 37.83 | 28152594 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAI3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAI3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
T2FB_HUMAN | GTF2F2 | physical | 22939629 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00755 | Tretinoin |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345; TYR-347 ANDTYR-350, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-347 AND TYR-350, ANDMASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317; TYR-320; TYR-347AND TYR-350, AND MASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317, AND MASSSPECTROMETRY. |